Bellerophon Therapeutics, Inc. (BLPH) Financials

BLPH Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 5.0 million 1.3 million
2023-06-30 11.2 million 5.6 million
2023-03-31 16.0 million 5.4 million
2022-12-31 7.9 million 5.4 million

BLPH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.3 million 21000
2023-06-30 -4.9 million 133000
2023-03-31 3.3 million 264000
2022-12-31 -4.4 million 162000

BLPH Net Income

No data available :(

BLPH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 4.4 million - -
2023-06-30 10.6 million - -
2023-03-31 15.2 million - 8000
2022-12-31 6.9 million - 203000

BLPH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 12.2 million
2023-06-30 12.2 million
2023-03-31 10.6 million
2022-12-31 9.6 million

BLPH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 544000 1.6 million -
2023-06-30 - 2.9 million 2.4 million -
2023-03-31 - 2.6 million 1.6 million -
2022-12-31 - 3.7 million 1.4 million -

BLPH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 5.6 million -
2022-12-31 - -

BLPH

Price: $0.06

52 week price:
0.03
12.55

Earnings Per Share: -0.89 USD

P/E Ratio: -0.07

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 18100

Ebitda: -6.1 million

Market Capitalization: 733956

Links: